Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LuX-Valve Plus System in Severe Tricuspid Regurgitation
NCT07705594Active, not recruiting
- Sponsor
- Jenscare Scientific
- Start
- Oct 2024
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Randomised, open-label trial in tricuspid regurgitation (2 arms), sponsored by Jenscare Scientific. Primary endpoints: Incidence rate of composite endpoint events at 6 months and Major Adverse Events at 30 days. Started Oct 2024; status: active, not recruiting.
02
Conditions
tricuspid regurgitation
Beyond the preview
Go deeper on NCT07705594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07705594.